HOOKIPA Pharma To Report Third Quarter 2020 Financial Results on November 12, 2020

NEXT STORY
Ascendis Pharma A/S Appoints Dr. Mark A. Bach as Senior Vice President of Clinical Development and Medical Affairs for Endocrinology Rare Diseases
PREV STORY
Affimed to Report 3rd Quarter 2020 Financial Results & Corporate Update November 10, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RedHill Biopharma Announces Completion of Enrollment for Confirmatory Phase III Study with TALICIA® for H. pylori Infection

Top-line results from the randomized, double-blind confirmatory Phase III study (ERADICATE Hp2 study) with ...

author_avatar
NASDAQ Market News

Athersys Reports Financial Results for Fourth Quarter, Full Year 2017

Company also announces equity investment and binding letter of intent to expand HEALIOS K.K. collaboration, ...

author_avatar
NASDAQ Market News

Emergent BioSolutions to Implement Stock Repurchase Program for Up to $50 Million of Its Common Stock

GAITHERSBURG, Md., July 15, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced ...

author_avatar
NASDAQ Market News